Overview
EN ISO 8536-15:2022/A1:2023 is an important international standard governing infusion equipment for medical use, specifically focusing on light-protective infusion sets for single use. Issued as Amendment 1 to ISO 8536-15:2022, this standard, developed by ISO/TC 76 in collaboration with CEN/TC 205, sets essential requirements for the design, materials, and performance of infusion sets that incorporate light-protective agents within the fluid path. This ensures the safe administration of photosensitive pharmaceutical solutions by preventing degradation caused by light exposure.
The standard aligns with global best practices and harmonizes requirements across many European nations, thereby facilitating consistent manufacturing quality and regulatory compliance. It addresses both technical specifications and biological safety, reinforcing patient safety during intravenous infusions.
Key Topics
-
Scope and Purpose
EN ISO 8536-15:2022/A1:2023 defines the parameters for infusion sets that are single-use and equipped with materials designed to block or reduce light exposure within the fluid path. This is critical for protecting photosensitive medications.
-
Material and Performance Specifications
The standard provides detailed guidelines on the composition of light-protective agents and their integration into medical-grade polymers used in infusion sets. This includes new recommendations on inner surface stability, mandating that no decolourization occurs, ensuring the integrity of the infusion solution.
-
Biological Safety and Risk Management
Incorporation of references to ISO 10993-17 and ISO 10993-18 strengthens the biological evaluation framework for material safety. Manufacturers must conduct chemical characterization and assess leachable substances to comply with allowable limits, reducing patient risk.
-
Testing Methods
The amendment introduces precise testing methods such as Annex C for decolourization assessment and chemical analysis aligned with the ISO biological evaluation framework, promoting reliable quality control.
-
Regulatory Impact
This amendment mandates national standards bodies across Europe to adopt or endorse the updated text by September 2023, ensuring widespread regulatory harmonization within healthcare markets.
Applications
EN ISO 8536-15:2022/A1:2023 is essential for organizations involved in the design, production, and quality assurance of single-use light-protective infusion sets. Its practical applications include:
-
Medical Device Manufacturers
Utilizing the standard ensures products meet stringent safety and performance criteria, enabling market access in regulated regions and enhancing product reliability when handling light-sensitive intravenous drugs.
-
Healthcare Providers and Hospitals
Selection and procurement of infusion sets compliant with this standard guarantee optimized patient care by minimizing risks linked to medication degradation caused by light exposure.
-
Regulatory Bodies
Adoption of the amendment supports harmonized evaluation of infusion equipment safety and efficacy, streamlining approvals and surveillance processes.
-
Testing Laboratories
Providing guidance on standardized testing protocols for material stability and chemical characterization supports compliance verification and certification.
Related Standards
The amendments and references in EN ISO 8536-15:2022/A1:2023 complement several important standards including:
-
ISO 10993-17: Biological evaluation of medical devices - Part 17
Establishes criteria for allowable limits of leachable substances, vital for chemical safety assessment of infusion set materials.
-
ISO 10993-18: Biological evaluation of medical devices - Part 18
Details chemical characterization procedures within risk management frameworks, reinforcing material biocompatibility.
-
ISO 8536 Series
Includes multiple parts addressing different types of infusion equipment, offering a comprehensive structure for infusion device standards.
-
United States Pharmacopeia (USP) Chapter 671
Referenced for chemical testing standards relevant to infusion systems.
By aligning infusion set design and testing with these related standards, manufacturers and healthcare institutions can ensure robust protection for patients receiving light-sensitive intravenous therapies.
This amendment to EN ISO 8536-15 reinforces the critical role of light-protective infusion sets in clinical practice, promoting enhanced patient safety and device reliability through updated materials’ performance criteria, biological evaluations, and rigorous testing requirements. Compliance with this standard is key for manufacturers and health systems striving for excellence in infusion therapy equipment.
